JNJ recently took over manufacturing at its own factory from a joint venture with what Cambridge UK based company, because of fuck ups?
AstraZeneca.
https://finance.yahoo.com/news/us-puts-johnson-johnson-charge-173228676.html
It's a bad AZ shot that was made in the joint venture factory with JNJ. AZ was kicked out for shit manufacturing.
This Johnson and Johnson vaccine issue is making normies think twice about getting ANY vaccine. Appointments are getting canceled. If this was a ruse to steer people into the mRNA vaccines, I don't think its working.
Almost Daily Grant's
Monday, April 12, 2021
Bit by Bit
Crypto broker Coinbase Global, Inc. is set to make its public debut on Wednesday, via a direct listing on the Nasdaq exchange under the ticker COIN. Projected valuation stands at $100 billion, compared to a combined $166 billion market cap across the Nasdaq, the Intercontinental Exchange (parent company of the New York Stock Exchange) and CME Group, and up from an $8 billion valuation in its most recent private funding round in 2018.
Reading the tea leaves, one legacy operator looks to get with the times. This afternoon, the NYSE announced on Twitter that it will sell so-called first trade non-fungible tokens, or digital renderings of IPO debut prints that “memorialize a company’s First Trade using the blockchain’s digital ledger and provide irrefutable proof of authenticity and ownership.”
***
The “inherent unpredictability” of Coinbase’s business noted in its Feb. 25 form S-1 filing can lead to big things when times are good. The company generated estimated net income of between $730 million to $800 million in the first quarter, far above the $128 million bottom line achieved during full-year 2020. Similarly, revenues soared to $1.8 billion over the first three months of 2021, compared to $1.3 billion throughout last year. Outsize price appreciation in the crypto complex underpinned those results, as bitcoin hovered near $60,000 this afternoon, up from $11,500 six months ago.
(6 fuckin captchas later)